menu
    • menu

    Company profile for Monte Rosa Therapeutics

    NEW Drugs in Dev.: 5
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Every cell has evolved sophisticated machinery to regulate the expression and function of proteins by degradation. This elaborate mechanism involves the controlled ubiquitination of protein substrates by E3 ligase complexes. Using rationally designed small molecule degraders (also known as molecular glues) our goal is to hijack this natural process and redirect the degradation machinery to specific disease-causing proteins.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Monte Rosa TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    645 Summer Street Boston, MA 02135 United States
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.monterosatx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/monte-rosa-therapeutics/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Monte Rosa Therapeutics Reports Strong Clinical Response
    Monte Rosa Therapeutics Reports Strong Clinical Response

    16 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/16/3206099/0/en/Monte-Rosa-Therapeutics-Announces-Compelling-Clinical-Activity-of-MRT-2359-in-Combination-with-Enzalutamide-in-Heavily-Pretreated-Metastatic-Castration-Resistant-Prostate-Cancer-Pa.html

    GLOBENEWSWIRE
    16 Dec 2025
    Share Share
    Monte Rosa Therapeutics To Unveil Latest MRT-2359 Study Results
    Monte Rosa Therapeutics To Unveil Latest MRT-2359 Study Results

    15 Dec 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/12/15/3205830/0/en/Monte-Rosa-Therapeutics-to-Present-Updated-MRT-2359-Phase-1-2-Study-Results.html

    GLOBENEWSWIRE
    15 Dec 2025
    Share Share
    Monte Rosa Shows Preclinical MRT-8102 Data For Cardio Diseases
    Monte Rosa Shows Preclinical MRT-8102 Data For Cardio Diseases

    08 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/08/3184076/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-AHA-Scientific-Sessions-2025-on-the-Potential-of-MRT-8102-a-NEK7-directed-Molecular-Glue-Degrader-to-Treat-Cardiovascular-and-C.html

    GLOBENEWSWIRE
    08 Nov 2025
    Share Share
    Monte Rosa Unveils MRT-6160, Data At ACR Convergence 2025
    Monte Rosa Unveils MRT-6160, Data At ACR Convergence 2025

    24 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/24/3172710/0/en/Monte-Rosa-Therapeutics-Presents-Preclinical-Data-at-ACR-Convergence-2025-on-the-Potential-of-MRT-6160-a-VAV1-directed-Molecular-Glue-Degrader-to-Treat-Immune-mediated-Diseases.html

    GLOBENEWSWIRE
    24 Oct 2025
    Share Share
    Novartis Signs up to $5.7 B licensing deal with Monte Rosa
    Novartis Signs up to $5.7 B licensing deal with Monte Rosa

    15 Sep 2025

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/novartis-signs-up-57-billion-licensing-deal-with-monte-rosa-therapeutics-2025-09-15/

    REUTERS
    15 Sep 2025
    Share Share
    Monte Rosa Therapeutics to Present at Investor Conferences
    Monte Rosa Therapeutics to Present at Investor Conferences

    02 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/02/3142482/0/en/Monte-Rosa-Therapeutics-to-Participate-in-Upcoming-Investor-Conferences.html

    GLOBENEWSWIRE
    02 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search